Compounds > 3'-azido-3'-deoxythymidine 5'phosphate
Page last updated: 2024-08-24

3'-azido-3'-deoxythymidine 5'phosphate and HIV

3'-azido-3'-deoxythymidine 5'phosphate has been researched along with HIV in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (71.43)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hall, ET; Kuchta, RD; Melançon, P; Yan, JP1
Jagannadh, B; Kunwar, AC; Reddy, DV1
Balzarini, J; Cahard, D; De Clercq, E; McGuigan, C; Naesens, L; Pathirana, R; Saboulard, D; Salgado, A; Velazquez, S1
Back, DJ; Barry, MG; Dann, L; Gibbons, SE; Hoggard, PG; Khoo, SH; Lloyd, J; Loveday, C; Wilkins, EG1
Johnson, S1
Civil, R; Downey, KM; Mian, AM; So, AG; Tan, CK1
Chu, CK; Colby, CB; Schinazi, RF; Sommadossi, JP; Williams, GJ; Zhu, Z1

Other Studies

7 other study(ies) available for 3'-azido-3'-deoxythymidine 5'phosphate and HIV

ArticleYear
3'-Azido-3'-deoxythymidine potently inhibits protein glycosylation. A novel mechanism for AZT cytotoxicity.
    The Journal of biological chemistry, 1994, May-20, Volume: 269, Issue:20

    Topics: Animals; CHO Cells; Cricetinae; Cytidine Monophosphate N-Acetylneuraminic Acid; Dideoxynucleotides; Glycosylation; Golgi Apparatus; HIV; HIV Infections; Humans; Intracellular Membranes; Kinetics; Membrane Proteins; Nucleoside Diphosphate Sugars; Protein Processing, Post-Translational; Thymine Nucleotides; Uridine Diphosphate Galactose; Uridine Diphosphate N-Acetylglucosamine; Zidovudine

1994
NMR study of dideoxynucleotides with anti-human immunodeficiency virus (HIV) activity.
    Journal of biochemical and biophysical methods, 1996, Feb-05, Volume: 31, Issue:3-4

    Topics: Antiviral Agents; Dideoxynucleotides; HIV; Humans; Inosine Triphosphate; Magnetic Resonance Spectroscopy; Models, Theoretical; Molecular Conformation; Molecular Structure; Thymine Nucleotides; Zidovudine

1996
Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine.
    Molecular pharmacology, 1999, Volume: 56, Issue:4

    Topics: Amino Acids; Animals; Anti-HIV Agents; Biotransformation; Dideoxynucleotides; Drug Design; Esterases; Esters; HIV; Humans; Liver; Male; Mice; Nucleosides; Prodrugs; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; Stavudine; Thymine Nucleotides; Tumor Cells, Cultured; Zidovudine

1999
Zidovudine phosphorylation determined sequentially over 12 months in human immunodeficiency virus-infected patients with or without previous exposure to antiretroviral agents.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:3

    Topics: Adult; Anti-HIV Agents; Dideoxynucleotides; Female; HIV; HIV Infections; Humans; Longitudinal Studies; Male; Middle Aged; Phosphorylation; Thymine Nucleotides; Zidovudine

2001
Low-dose, sublingual AZT-monophosphate therapy for HIV+ patients?
    Medical hypotheses, 2001, Volume: 56, Issue:3

    Topics: Administration, Sublingual; Anti-HIV Agents; Dideoxynucleotides; HIV; HIV Infections; HIV Seropositivity; Humans; Models, Biological; Thymidine Kinase; Thymine Nucleotides; Virus Replication; Zidovudine

2001
Inhibition of the RNase H activity of HIV reverse transcriptase by azidothymidylate.
    Biochemistry, 1991, May-21, Volume: 30, Issue:20

    Topics: Antiviral Agents; Cloning, Molecular; Deoxyribonucleotides; Dideoxynucleotides; Endoribonucleases; Escherichia coli; HIV; Kinetics; Nucleic Acid Synthesis Inhibitors; Recombinant Proteins; Reverse Transcriptase Inhibitors; Ribonuclease H; Ribonucleotides; RNA-Directed DNA Polymerase; Thymine Nucleotides; Zidovudine

1991
Cellular metabolism of 3'-azido-2',3'-dideoxyuridine with formation of 5'-O-diphosphohexose derivatives by previously unrecognized metabolic pathways for 2'-deoxyuridine analogs.
    Molecular pharmacology, 1990, Volume: 38, Issue:6

    Topics: Antiviral Agents; Bone Marrow; Chromatography, High Pressure Liquid; Dideoxynucleotides; HIV; Humans; Leukocytes, Mononuclear; Thymine Nucleotides; Zidovudine

1990